Stem cells are undifferentiated biological cells which produce indefinitely more identical stem cells through mitosis. Rising investments in research and development of therapeutic value for chronic syndromes are driving the stem cells market. In addition, augmenting demand for regenerative treatment are responsible for growth in this market. Government interventions in drug development and discovery are growing in this market owing to the unmet medical prerequisites worldwide.
This report examines the global stem cells market and provides information regarding the revenue (USD Million) for the period 2014 to 2021. It further elaborates the market drivers which contribute to the growth. It then describes the restraints that are faced by the market. The market is classified into various segments with deep analysis of each segment for the study period.
Report includes a detailed analysis on value chain in order to provide a holistic view of the stem cells market. Value chain analysis comprises detailed evaluation of the roles of various players involved in the stem cells industry, from raw material suppliers to end-users.
Porter’s five forces model has been used to depict the impact of various factors such as:
- Degree of competition
- Bargaining power of suppliers
- Threat of substitutes
- Bargaining power of buyers
- Threat of new entrants during the forecast period
Market attractiveness analysis has been included in order to analyze the application segments that are estimated to be lucrative during the forecast period on the basis of their market size and growth rate. Attractiveness of the market has been derived from market size, profit margin, growth rate, availability of raw materials, competition, and other factors such as social and legal constraints.
The stem cells market has further been segmented based on product such as adult stem cells (hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells, umbilical cord stem cells), human embryonic stem cells, induced pluripotent stem cells, natural rosette cells and very small embryonic like stem cells. The study provides forecast and estimates market for each type in terms of revenue and volume during the forecast period from 2015 to 2021. Each type has been further analyzed based on regional and country levels from 2014 to 2021 in terms of volume and revenue.
The stem cells market has been segmented based on applications such as regenerative medicine (neurology, orthopedics, oncology, hematology, cardiovascular and myocardial infraction, injuries, diabetes, liver disorder, incontinence including Crohn’s disease, infertility, immunodeficiency disorder, organ transplants, ophthalmic disorder) and drug discovery and development. The study provides forecast and estimates market for each application in terms of revenue and volume during the forecast period from 2015 to 2021. Each application has been further analyzed based on regional and country levels from 2014 to 2021 in terms of volume and revenue.
The stem cells market has been segmented based on technology such as cell acquisition (bone marrow harvest, apheresis and umbilical blood cord), cell production (therapeutic cloning, in vitro fertilization, isolation and cell culture), cryopreservation and expansion and sub-culture. The study provides forecast and estimates market for each application in terms of revenue and volume during the forecast period from 2015 to 2021. Each application has been further analyzed based on regional and country levels from 2014 to 2021 in terms of volume and revenue.
In terms of geography, the stem cells market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue and volume during the forecast period.
The report also offers a competitive landscape of the overall market with company profiles of players such as Advanced Cell Technology Inc., Angel Biotechnology, Bioheart Inc., BioTime Inc., BrainStorm Cell Therapeutics, California Stem Cells Inc., Celgene Corporation, Cellartis AB, Cellular Engineering Technologies Inc., Cytori Therapeutics Inc., Osiris Therapeutics and STEMCELL Technologies Inc. A detailed description of the each company has been included and includes information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments provides a thorough idea about the competitive positioning of market players. The report also provides stem cells market's Mergers/acquisitions, Partnerships, Collaborations, New product lunches, new product developments and other industry developments.
Combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific Details on methodology used for this report can be provided on demand.
SEGMENTATIONS IN REPORT:
Stem Cells By Product
Stem Cells By Application
- Adult Stem Cells
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Neuronal Stem Cells
- Dental Stem Cells
- Umbilical Cord Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Natural Rosette Cells
- Very Small Embryonic Like Stem Cells
Stem Cells By Technology
- Regenerative Medicine
- Cardiovascular and Myocardial Infraction
- Liver Disorder
- Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
- Drug Discovery and Development
Stem Cells By Geography:
- Cell Acquisition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Cell Production
- Therapeutic Cloning
- In Vitro Fertilization
- Cell Culture
- Expansion and Sub-Culture
- Asia Pacific
- North America
- Latin America
- Middle East And Africa